Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma Nicolas AideCharline LasnonGandhi Damaj Editorial Commentary 17 February 2018 Pages: 677 - 679
Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma Mathieu Nessim ToledanoP. DesbordesS. Becker Original Article 17 January 2018 Pages: 680 - 688
Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy Wing-Keen YapYu-Chuan ChangTsung-Min Hung Original Article 30 November 2017 Pages: 689 - 698
Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma Nicolas AideMarjolaine TalbotCharline Lasnon Original Article Open access 07 December 2017 Pages: 699 - 711
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe) Cristina NanniAnnibale VersariElena Zamagni Original Article 21 December 2017 Pages: 712 - 719
Preoperative prediction of microvascular invasion of hepatocellular carcinoma using 18F-FDG PET/CT: a multicenter retrospective cohort study Seung Hyup HyunJae Seon EoMijin Yun Original Article 22 November 2017 Pages: 720 - 726
Comparison of positron emission tomography/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapy Tzu-Pei SuGigin LinChyong-Huey Lai Original Article 20 November 2017 Pages: 727 - 734
Value of 18F–FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients Zhilei LvJinshuo FanYang Jin Original Article Open access 21 November 2017 Pages: 735 - 750
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis Pietro GhediniI. BossertC. Nanni Original Article 30 November 2017 Pages: 751 - 758
Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer Kee H. WongRafal PanekKate L. Newbold Original Article Open access 21 November 2017 Pages: 759 - 767
Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy François LuciaDimitris VisvikisUlrike Schick Original Article 09 December 2017 Pages: 768 - 786
Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric population Abhishek JhaAlexander LingKarel Pacak Original Article 04 December 2017 Pages: 787 - 797
The diagnostic value of 18F–FDG-PET/CT and MRI in suspected vertebral osteomyelitis – a prospective study Ilse J. E. KouijzerHenk ScheperLioe-Fee de Geus-Oei Original Article Open access 19 December 2017 Pages: 798 - 805
Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF) Thida WinNicholas J. ScreatonAshley M. Groves Original Article Open access 16 January 2018 Pages: 806 - 815
Life is not black and white, nor just Shades of Gray T. BeyerR. J. HicksL. S. Freudenberg Editorial 08 February 2018 Pages: 816 - 821
Bone radionuclide therapy and increased survival with radium-223 is the way to go for nuclear medicine: the offer that oncologists cannot refuse Roberto C. Delgado BoltonFrancesco Giammarile Editorial 14 January 2018 Pages: 822 - 823
EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer Thorsten D. PoeppelDaria Handkiewicz-JunakMichael Gabriel Guidelines 12 December 2017 Pages: 824 - 845
EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides Daria Handkiewicz-JunakThorsten D. PoeppelMichael Gabriel Guidelines Open access 16 February 2018 Pages: 846 - 859
Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives Philipp BackhausBenjamin NotoKambiz Rahbar Review Article 15 January 2018 Pages: 860 - 877
Reply to: “All that glitters is not gold – new reconstruction methods using Deauville criteria for patient reporting” Charline LasnonBlandine EniloracNicolas Aide Letter to the Editor 23 February 2018 Pages: 878 - 881
Interim FDG PET/CT in primary mediastinal diffuse large B-cell lymphoma: really almost useless procedure? Vít ProcházkaLenka HenzlováTomáš Papajík Letter to the Editor 03 February 2018 Pages: 882 - 883
Reply: Interim FDG-PET/CT in primary mediastinal diffuse large B-cell lymphoma: really almost useless procedure? Julien LazaroviciMarie Terroir-Cassou-MounatDavid Ghez Reply 17 February 2018 Pages: 884 - 885
Glioblastoma multiforme: another potential application for 68Ga-PSMA PET/CT as a guide for targeted therapy Jolanta KunikowskaKrólicki BartoszKrólicki Leszek Image of the Month 31 January 2018 Pages: 886 - 887
Solitary testicular metastasis from prostate cancer. A case report diagnosed by PET/CT with PSMA Marcelo Livorsi da CunhaCamila de Oliveira RodriguesRobson Ferrigno Image of the Month 06 February 2018 Pages: 888 - 889
H. William Strauss, Giuliano Mariani, Duccio Volterrani, Steven M. Larson (editors): Nuclear Oncology: From Pathophysiology to Clinical Applications, second edition Carmela NappiLuigi Mansi Book Review 20 January 2018 Pages: 890 - 890
Yuji Kuge, Tohru Shiga, Nagara Tamaki (editors): Perspectives on nuclear medicine for molecular diagnosis and integrated therapy Ida AnnarummaLuigi Mansi Book Review 27 January 2018 Pages: 891 - 891
